Teva Pharma Boosts Outlook For Key Innovative Drugs Austedo, Ajovy, Uzedy

benzinga.com/markets/earnings/25/07/46731358/teva-reaffirms-2025-sales-boosts-outlook-for-austedo-ajovy-uzedy

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) reported its second-quarter 2025 financial results on Wednesday, reflecting a mixed performance amid continued shifts in its portfolio strategy.
The company reported total revenue of $4.20 billion, falling short of analysts’ expectations of…

This story appeared on benzinga.com, 2025-07-30 17:15:45.
The Entire Business World on a Single Page. Free to Use →